NCT03425279 2025-09-23CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With SarcomaBioAtla, Inc.Phase 1/2 Completed245 enrolled
NCT06370871 2024-07-17Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue SarcomaBoehringer IngelheimPhase 3 Withdrawn
NCT01962103 2019-12-27Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid TumorsCelgenePhase 1/2 Completed107 enrolled 42 charts
NCT00171912 2017-02-23Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase EnzymesNovartisPhase 2 Completed38 enrolled
NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled